Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Multiple Myeloma Minimal Residual Disease

NCT02627261

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Hôpital Huriez Lille, France

Centre Hospitalier Universitaire Hôtel-Dieu de Nantes Nantes, France

Centre Hospitalier Lyon Sud Pierre Bénité, France

View Trial Details

Completed

Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT

NCT00599495

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

View Trial Details

Completed

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

NCT03619252

Conditions: Agranulocytosis, Bacterial Infections, Bacterial Infections and Mycoses, +32 more
Locations: Minsk Scientific Practical Center of Surgery, Transplantation and Hematology, Belarus Minsk, Belarus

View Trial Details

Completed

Non-interventional Study With Pomalidomide (Imnovid®)

NCT02075996

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: iOMEDICO AG Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma

NCT00784823

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

NCT01119066

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +23 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients

NCT02384083

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Instoitut Català d'Oncologia Badalona, Spain

Hospital Clinico Universitario Barcelona, Spain

Hospital Doce de Octubre Madrid, Spain

Hospital Morales Messeguer Murcia, Spain

View Trial Details

Completed

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT03650491

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

NCT02921828

Conditions: Acute Kidney Injury, Arrhythmias, Cardiac, Blood Protein Disorders, +54 more
Locations: Local Institution - Japan No City Provided, New Jersey, United States

Shinko Hospital Kobe, Hyōgo, Japan

View Trial Details

Completed

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

NCT00900055

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +29 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions